This review surveys the related developments that have taken place in the period 2004–2009 since the promotion of Process Analytical Technology (PAT) by the U.S. Food and Drug Administration (FDA).
No takes yet. Share an insight, caveat, or question.
Chew et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: